Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby M Maher

Showing results (251-260 of 391) with videos related to

Pageof 40
Sort By:
Advances in Bioscience and Biotechnology (Print)|January 29, 2013
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblastsThomas H Sisson, Toby M Maher, Iyabode O Ajayi, et al.
The European Respiratory Journal|March 24, 2012
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypesTaryn L Reddy, Masaki Tominaga, David M Hansell, et al.
BMJ Open Respiratory Research|March 10, 2026
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trialWim A Wuyts, Lisa Lancaster, Toby M Maher, et al.
Clinical Science (London, England : 1979)|January 9, 2016
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisIona C Evans, Josephine L Barnes, Ian M Garner, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Type 1 Invariant Natural Killer T Cells Drive Lung FibrosisEmily Calamita, Wing Han Liu, Patricia P Ogger, et al.
BMJ Open Respiratory Research|January 28, 2026
Prospective study of fibrosis in the lung endpoints (PROFILE): characteristics of an incident cohort of patients with idiopathic pulmonary fibrosisToby M Maher, Gisli R Jenkins, Gauri Saini, et al.
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Advances in Therapy|October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial DesignEva Santermans, Paul Ford, Michael Kreuter, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2021
DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung FibrosisPeter McErlean, Christopher G Bell, Richard J Hewitt, et al.
Pageof 40

Showing results (251-260 of 391) with videos related to

Sort By:
Pageof 40
Advances in Bioscience and Biotechnology (Print)|January 29, 2013
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblastsThomas H Sisson, Toby M Maher, Iyabode O Ajayi, et al.
The European Respiratory Journal|March 24, 2012
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypesTaryn L Reddy, Masaki Tominaga, David M Hansell, et al.
BMJ Open Respiratory Research|March 10, 2026
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trialWim A Wuyts, Lisa Lancaster, Toby M Maher, et al.
Clinical Science (London, England : 1979)|January 9, 2016
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisIona C Evans, Josephine L Barnes, Ian M Garner, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Type 1 Invariant Natural Killer T Cells Drive Lung FibrosisEmily Calamita, Wing Han Liu, Patricia P Ogger, et al.
BMJ Open Respiratory Research|January 28, 2026
Prospective study of fibrosis in the lung endpoints (PROFILE): characteristics of an incident cohort of patients with idiopathic pulmonary fibrosisToby M Maher, Gisli R Jenkins, Gauri Saini, et al.
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Advances in Therapy|October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial DesignEva Santermans, Paul Ford, Michael Kreuter, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2021
DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung FibrosisPeter McErlean, Christopher G Bell, Richard J Hewitt, et al.
Pageof 40